Drug-Resistant Epilepsy Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 September 22
SKU : PH6803
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
FAQ’s
What is the Projected CAGR value of the Drug Resistant Epilepsy Market ?
Drug Resistant Epilepsy Market is expected to grow at a CAGR of 4.4% during the forecast period 2023-2030.
Who are the key players in Drug Resistant Epilepsy Market ?
Major players are Jazz Pharmaceuticals, LivaNova PLC:, NeuroPace, Inc, Avenue Therapeutics, Xenon Pharmaceuticals Inc and UCB S.A.